Benzinga's Top Ratings Upgrades, Downgrades For May 25, 2022
Upgrades
Credit Suisse upgraded the previous rating for Molecular Partners AG NASDAQ:MOLN from Underperform to Neutral. NoneAt the moment, the stock has a 52-week-high of
Mizuho upgraded the previous rating for Sabra Health Care REIT Inc NASDAQ:SBRA from Neutral to Buy. For the first quarter, Sabra Health Care REIT had an EPS of
According to JP Morgan, the prior rating for Magellan Midstream Partners LP NYSE:MMP was changed from Neutral to Overweight. In the first quarter, Magellan Midstream showed an EPS of
Barclays upgraded the previous rating for Diamondback Energy Inc NASDAQ:FANG from Equal-Weight to Overweight. For the first quarter, Diamondback Energy had an EPS of
According to Oppenheimer, the prior rating for CME Group Inc NASDAQ:CME was changed from Perform to Outperform. For the first quarter, CME Group had an EPS of
According to Wells Fargo, the prior rating for Univar Solutions Inc NYSE:UNVR was changed from Equal-Weight to Overweight. Univar Solns earned
For Kilroy Realty Corp NYSE:KRC, Goldman Sachs upgraded the previous rating of Neutral to Buy. Kilroy Realty earned
Atlantic Equities upgraded the previous rating for Air Products & Chemicals Inc NYSE:APD from Neutral to Overweight. For the second quarter, Air Products & Chemicals had an EPS of
JP Morgan upgraded the previous rating for Equitable Holdings Inc NYSE:EQH from Neutral to Overweight. Equitable Holdings earned
See all analyst ratings upgrades.
Downgrades
For Fisker Inc NYSE:FSR, Tudor Pickering downgraded the previous rating of Buy to Hold. For the first quarter, Fisker had an EPS of
According to
For Best Buy Co Inc NYSE:BBY, Barclays downgraded the previous rating of Overweight to Equal-Weight. In the first quarter, Best Buy Co showed an EPS of
Goldman Sachs downgraded the previous rating for Essential Properties Realty Trust Inc NYSE:EPRT from Buy to Neutral. In the first quarter, Essential Props Realty showed an EPS of
According to Barclays, the prior rating for Devon Energy Corp NYSE:DVN was changed from Overweight to Equal-Weight. Devon Energy earned
According to Credit Suisse, the prior rating for ASGN Inc NYSE:ASGN was changed from Neutral to Underperform. ASGN earned
RBC Capital downgraded the previous rating for Verrica Pharmaceuticals Inc NASDAQ:VRCA from Outperform to Sector Perform. Verrica Pharmaceuticals earned
For 2U Inc NASDAQ:TWOU, Piper Sandler downgraded the previous rating of Neutral to Underweight. 2U earned
See all analyst ratings downgrades.
Initiations
Cantor Fitzgerald initiated coverage on Pliant Therapeutics Inc NASDAQ:PLRX with an Overweight rating. The price target for Pliant Therapeutics is set to
With an Outperform rating, Northland Capital Markets initiated coverage on Generac Holdings Inc NYSE:GNRC. The price target seems to have been set at
With a Buy rating, Craig-Hallum initiated coverage on POET Technologies Inc NASDAQ:POET. The price target seems to have been set at
Cowen & Co. initiated coverage on Wallbox NV NYSE:WBX with an Outperform rating. The price target for Wallbox is set to
With an Outperform rating, Cowen & Co. initiated coverage on Allegro Microsystems Inc NASDAQ:ALGM. The price target seems to have been set at
With a Equal-Weight rating, Wells Fargo initiated coverage on Murphy USA Inc NYSE:MUSA. The price target seems to have been set at
With a Equal-Weight rating, Wells Fargo initiated coverage on ARKO Corp NASDAQ:ARKO. The price target seems to have been set at
With a Market Outperform rating, JMP Securities initiated coverage on Pharvaris NV NASDAQ:PHVS. The price target seems to have been set at
With a Neutral rating,
With a Neutral rating, Piper Sandler initiated coverage on Amyris Inc NASDAQ:AMRS. The price target seems to have been set at
B of A Securities initiated coverage on ALLETE Inc NYSE:ALE with a Neutral rating. The price target for ALLETE is set to
With a Buy rating, Citigroup initiated coverage on Amylyx Pharmaceuticals Inc NASDAQ:AMLX. The price target seems to have been set at
Wells Fargo initiated coverage on Casey's General Stores Inc NASDAQ:CASY with an Overweight rating. The price target for Casey's General Stores is set to
With a Buy rating, Chardan Capital initiated coverage on SQZ Biotechnologies Co NYSE:SQZ. The price target seems to have been set at
With a Buy rating,
With a Neutral rating,
Goldman Sachs initiated coverage on Cazoo Group Ltd NYSE:CZOO with a Neutral rating. The price target for Cazoo Gr is set to
See all analyst ratings initiations.